KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

S. Rodenhuis, S. S. Wagenaar, W. J. Mooi, A. J. M. Boot, R. J. C. Slebos, P. C. Van Bodegom, S. G. Evers, J. L. Bos, Incidence and Possible Clinical Significance of K- ras Oncogene Activation in Adenocarcinoma of the Human Lung Cancer Research. ,vol. 48, pp. 5738- 5741 ,(1988)

Steven A. Ahrendt, P. Anthony Decker, Enas A. Alawi, Yong-ran Zhu, Montserrat Sanchez-Cespedes, Stephen C. Yang, George B. Haasler, André Kajdacsy-Balla, Michael J. Demeure, David Sidransky, Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer. ,vol. 92, pp. 1525- 1530 ,(2001) , 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H

Sjoerd Rodenhuis, Robert J. C. Slebos, TherasOncogenes in Human Lung Cancer American Review of Respiratory Disease. ,vol. 142, pp. S27- S30 ,(1990) , 10.1164/AJRCCM/142.6_PT_2.S27

Y. Suzuki, Y. Murakami, M. Orita, K. Hayashi, T. Sekiya, Detection of DNA aberrations in human cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products Mutation Research\/environmental Mutagenesis and Related Subjects. ,vol. 253, pp. 279- ,(1991) , 10.1016/0165-1161(91)90223-U

Adi F. Gazdar, Hisayuki Shigematsu, Joachim Herz, John D. Minna, Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers? Trends in Molecular Medicine. ,vol. 10, pp. 481- 486 ,(2004) , 10.1016/J.MOLMED.2004.08.008

Raffaella Sordella, Daphne W Bell, Daniel A Haber, Jeffrey Settleman, Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways Science. ,vol. 305, pp. 1163- 1167 ,(2004) , 10.1126/SCIENCE.1101637

Shoji Mashiyama, Takamasa Kayama, Ryuichi Katakura, Takashi Yoshimoto, Yoshinori Murakami, Takao Sekiya, Kenshi Hayashi, Detection of p53 Gene Mutations in Human Brain Tumors by Single-strand Conformation Polymorphism Analysis of Polymerase Chain Reaction Products Oncogene. ,vol. 5, pp. 1037- 1043 ,(1991) , 10.1007/978-4-431-68150-2_41

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938

Philip Stephens, Chris Hunter, Graham Bignell, Sarah Edkins, Helen Davies, Jon Teague, Claire Stevens, Sarah O'meara, Raffaella Smith, Adrian Parker, Andy Barthorpe, Matthew Blow, Lisa Brackenbury, Adam Butler, Oliver Clarke, Jennifer Cole, Ed Dicks, Angus Dike, Anja Drozd, Ken Edwards, Simon Forbes, Rebecca Foster, Kristian Gray, Chris Greenman, Kelly Halliday, Katy Hills, Vivienne Kosmidou, Richard Lugg, Andy Menzies, Janet Perry, Robert Petty, Keiran Raine, Lewis Ratford, Rebecca Shepherd, Alexandra Small, Yvonne Stephens, Calli Tofts, Jennifer Varian, Sofie West, Sara Widaa, Andrew Yates, Francis Brasseur, Colin S Cooper, Adrienne M Flanagan, Margaret Knowles, Suet Y Leung, David N Louis, Leendert HJ Looijenga, Bruce Malkowicz, Marco A Pierotti, Bin Teh, Georgia Chenevix-Trench, Barbara L Weber, Siu T Yuen, Grace Harris, Peter Goldstraw, Andrew G Nicholson, P Andrew Futreal, Richard Wooster, Michael R Stratton, None, Intragenic ERBB2 kinase mutations in tumours Nature. ,vol. 431, pp. 525- 526 ,(2004) , 10.1038/431525B

W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi, I. Sarkaria, B. Singh, R. Heelan, V. Rusch, L. Fulton, E. Mardis, D. Kupfer, R. Wilson, M. Kris, H. Varmus, EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 13306- 13311 ,(2004) , 10.1073/PNAS.0405220101